| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/04/2007 | US20070004004 comprising a nucleotide sequence of a mutated TipA gene promoter is capable of thiostrepton-independent and constitutive expression of a gene located downstream |
| 01/04/2007 | US20070004003 Koji mold-origin phospholipase a2 |
| 01/04/2007 | US20070004002 Stably, extrachromosomally held in mammalian host cells, allows efficient expression of a target gene; first cyclic vector contains centromere sequence, selection marker gene; second vector contains functional sequence transferred into mammalian host cells |
| 01/04/2007 | US20070004000 Process for producing isoprenoid compounds by microorganisms and a method for screening compounds with antibiotic or weeding activity |
| 01/04/2007 | US20070003999 Polypeptides, nucleic acids; gene codes; antibiotic, immunosuppressants; identifying a novel secondary metabolite biosynthesis gene cluster in a fungus |
| 01/04/2007 | US20070003973 Methods and kits for identifying and quantifying RNAs and DNAs associated with RNA and DNA binding proteins |
| 01/04/2007 | US20070003971 Determining the identity of biallelic markers at a particular position of a FLAP gene and using that information to evaluate whether an individual is at increased risk of asthma |
| 01/04/2007 | US20070003968 Methods of detecting polynucleotide kinase and its use as a label |
| 01/04/2007 | US20070003963 RNA sequence-specific mediators of RNA interference |
| 01/04/2007 | US20070003962 Used in targeting specific mRNAs for degradation in mammalian cells where use of long dsRNAs to elicit RNAi is usually not practical, presumably because of the deleterious effects of the interferon response |
| 01/04/2007 | US20070003961 Used in targeting specific mRNAs for degradation in mammalian cells where use of long dsRNAs to elicit RNAi is usually not practical, presumably because of the deleterious effects of the interferon response |
| 01/04/2007 | US20070003960 Producing knockdown cells; Used in targeting specific mRNAs for degradation in mammalian cells where use of long dsRNAs to elicit RNAi is usually not practical, presumably because of the deleterious effects of the interferon response |
| 01/04/2007 | US20070003946 Use of biomarkers in screening for insulin resistance |
| 01/04/2007 | US20070003942 Invasive cleavage of nucleic acids |
| 01/04/2007 | US20070003934 2-Methyl-6-solanylbenzoquinone methyltransferase as target for herbicides |
| 01/04/2007 | US20070003932 Method of detecting beta 3 adrenaline receptor mutant gene and nucleic acid probe and kit therefor |
| 01/04/2007 | US20070003930 Handling of dna |
| 01/04/2007 | US20070003929 Method for identifying, analyzing and/or cloning nucleic acid isoforms |
| 01/04/2007 | US20070003926 Nucleic acid sequences from drosophila melanogaster that encode proteins essential for viability and uses thereof |
| 01/04/2007 | US20070003923 Modified fiber proteins for efficient receptor binding |
| 01/04/2007 | US20070003668 Nucleic acid encoding polypeptide having lactose permease activity; multidrug transporter; useful for modifying plants |
| 01/04/2007 | US20070003667 Encodes a polypeptide having aminopeptidase activity; useful in the selection and production of recombinant bacteria, particularly the production of bacteria with improved fermentative abilities |
| 01/04/2007 | US20070003609 Vectorization of dsRNA by cationic particles and topical use |
| 01/04/2007 | US20070003607 Neutral liposome-encapsulated compounds and methods of making and using thereof |
| 01/04/2007 | US20070003578 Chimeric protein comprising non-toxic pseudomonas exotoxin and type IV pilin sequences |
| 01/04/2007 | US20070003576 Vaccines for the rapid response to pandemic avian influenza |
| 01/04/2007 | US20070003575 Viral and viral associated MiRNAs and uses thereof |
| 01/04/2007 | US20070003574 antibody or antiserum directed against a structural protein of Ljungan picornavirus; cardiovascular, nervous system and metabolic disorders; Myocarditis, Cardiomyopathia, Guillain Barre Syndrome, and Diabetes Mellitus, Multiple Sclerosis, Chronic Fatigue Syndrome, Myasthenia Gravis |
| 01/04/2007 | US20070003573 Viral expression vector for use in the treatment and diagnosis of viral, cardiovascular, nervous system and metabolic disorders |
| 01/04/2007 | US20070003572 Polynucleotides and polypeptides encoded by the depicted nucleic acid sequences which may be used as medicaments, vaccines or diagnostic substances, preferably for the treatment, prevention or diagnosis of HIV infections |
| 01/04/2007 | US20070003571 Modified herpes simplex viral particle for targeting and destroying tumor cells |
| 01/04/2007 | US20070003569 Recombinant polypeptides, which can be used as purified antigens for the detection and control of tuberculosis |
| 01/04/2007 | US20070003568 Secreted chlamydia polypeptides, polynucleotides coding therefor, therapeutic and diagnostic uses thereof |
| 01/04/2007 | US20070003567 Composition and methods for enhancing immunogenecity of antigens |
| 01/04/2007 | US20070003566 Polyepitope carrier protein |
| 01/04/2007 | US20070003562 Chimera molecule containing protein and merozoites surface protein; induce immunology response against antigen |
| 01/04/2007 | US20070003560 Humanized monoclonal antibodies that protect against shiga toxin induced disease |
| 01/04/2007 | US20070003553 Anticoagulant agents useful in treatment of thrombosis |
| 01/04/2007 | US20070003551 Immunoglobulin |
| 01/04/2007 | US20070003548 Anti-TNF antibodies, compositions, methods and uses |
| 01/04/2007 | US20070003547 Super humanized antibodies |
| 01/04/2007 | US20070003540 Stem cells having increased sensitivity to sdf-1 and methods of generating and using same |
| 01/04/2007 | US20070003534 Comprehensive analysis of transcription control factor complexes in a mouse brain cDNA library with c-Jun as a bait by using the cotranslation selection and screening of in vitro virus (IVV) and the C-terminal labeling method |
| 01/04/2007 | US20070003533 Inhibition of the beta3 subunit of L-type Ca2+ channels |
| 01/04/2007 | US20070003524 Targeted retrograde gene delivery to motor neurons |
| 01/04/2007 | US20070003523 Short interference ribonuclic acids for treatment and prevention of diabetic retinopathy, age related macular degeneration and cancer; gene expression inhibition |
| 01/04/2007 | US20070003522 Methods and compositions for improved retroviral gene and drug delivery |
| 01/04/2007 | US20070003521 Expression vectors containing hybrid ubiquitin promoters |
| 01/04/2007 | US20070003520 Mutant viruses |
| 01/04/2007 | US20070003519 reducing ICT1024 expression; inhibitor is an siRNA, shRNA, antisense RNA, antisense DNA, decoy molecule, decoy DNA, double stranded DNA, single-stranded DNA, complexed DNA, encapsulated DNA, viral DNA, plasmid DNA, naked RNA, encapsulated RNA, viral RNA, double stranded RNA, RNA interference; cancer |
| 01/04/2007 | US20070003518 Raav vector-based compositions and methods for the prevention and treatment of mammalian diseases |
| 01/04/2007 | DE112004002408T5 Verfahren zur Gewinnung einer angereicherten Population von siRNA-exprimierenden Zellen A process for obtaining an enriched population of siRNA-expressing cells |
| 01/04/2007 | CA2755369A1 Nucleotide sequence mediating plant male fertility and method of using same |
| 01/04/2007 | CA2755243A1 Nucleotide sequence mediating plant male fertility and method of using same |
| 01/04/2007 | CA2617222A1 Peptide derived from prostate-related protein as cancer vaccine candidate for prostate cancer patient who is positive for hla-a3 super-type allele molecule |
| 01/04/2007 | CA2613697A1 Components of cell culture media produced from plant cells |
| 01/04/2007 | CA2613654A1 Hecgf-1 related polymorphisms and applications thereof |
| 01/04/2007 | CA2613529A1 Reporter hepatocytes and other cells for drug screening and toxicity testing |
| 01/04/2007 | CA2613494A1 Amelioration of inflammatory arthritis by targeting the pre-ligand assembly domain (plad) of tumor necrosis factor receptors |
| 01/04/2007 | CA2613336A1 Nucleotide sequences mediating plant male fertility and method of using same |
| 01/04/2007 | CA2613284A1 Methods and compositions for expressing negative-sense viral rna in canine cells |
| 01/04/2007 | CA2613082A1 Method for identifying modulators of rufy2 useful for treating alzheimer's disease |
| 01/04/2007 | CA2613028A1 Peptidic antagonists of class iii semaphorins/neuropilins complexes |
| 01/04/2007 | CA2613008A1 Using cytosine deaminases to diminish retroelement transfer from pigs to humans |
| 01/04/2007 | CA2612760A1 Il-1.beta. binding antibodies and fragments thereof |
| 01/04/2007 | CA2612486A1 Anti-cd71 monoclonal antibodies and uses thereof for treating malignant tumour cells |
| 01/04/2007 | CA2612465A1 Delivery of active proteins to the central nervous system using phage vectors |
| 01/04/2007 | CA2612378A1 Methods and compositions for targeting ifnar2 |
| 01/04/2007 | CA2612143A1 Gfats as modifiers of the axin pathway and methods of use |
| 01/04/2007 | CA2611820A1 Prrs viruses, infectious clones, mutants thereof, and methods of use |
| 01/04/2007 | CA2610995A1 A device including a proteinaceous factor, a recombinant proteinaceous factor, and a nucleotide sequence encoding the proteinaceous factor |
| 01/04/2007 | CA2609142A1 Therapeutic gene vectors comprising mirna target sequences |
| 01/04/2007 | CA2608964A1 Rnai modulation of hif-1 and therapeutic uses thereof |
| 01/04/2007 | CA2583121A1 Immunogenic compositions of staphylococcus epidermidis polypeptide antigens |
| 01/03/2007 | EP1739584A1 Document information processing system |
| 01/03/2007 | EP1739424A1 Rapid and quantitative proteome anaysis and related methods |
| 01/03/2007 | EP1739186A1 Method of screening compound capable of accelerating or inhibiting apoptosis, apoptosis accelerator and apoptosis inhibitor |
| 01/03/2007 | EP1739182A1 Process for producing polyhydroxyalkanoate |
| 01/03/2007 | EP1739180A1 T cell line-based packaging cell line for the production of retroviruses by enriching of CD3 expressing cells |
| 01/03/2007 | EP1739179A1 Serum-free stable transfection and production of recombinant human proteins in human cell lines |
| 01/03/2007 | EP1739178A2 Delivery of trefoil peptides |
| 01/03/2007 | EP1739177A1 Antibodies against interferon alpha/beta receptor |
| 01/03/2007 | EP1739176A1 Decoy nucleic acid to synoviolin gene promoter |
| 01/03/2007 | EP1739175A1 Method for detecting microRNA |
| 01/03/2007 | EP1739174A1 Mutated glucose dehydrogenase |
| 01/03/2007 | EP1739173A1 Kit for solid cancer diagnosis and medicine for solid cancer therapy |
| 01/03/2007 | EP1739172A1 Genetic marker linked to gene locus involved in barley resistance to yellow mosaic disease and use thereof |
| 01/03/2007 | EP1739171A1 Novel gene participating in epidermal differentiation and use thereof |
| 01/03/2007 | EP1739170A2 Transgenic animals expressing human coagulation factor VIII and von Willebrand factor |
| 01/03/2007 | EP1739168A2 Neoplasia-specific splice variants and methods |
| 01/03/2007 | EP1739091A1 Trefoil peptide dimer |
| 01/03/2007 | EP1739090A2 Interferon-beta fusion proteins and uses |
| 01/03/2007 | EP1738829A1 Polymerase chain reaction system |
| 01/03/2007 | EP1738772A1 Micro rna inhibiting the expression of wt1 gene and utilization of the same |
| 01/03/2007 | EP1738771A1 siRNA CAPABLE OF INHIBITING EXPRESSION OF WT1 GENE AND USE THEREOF |
| 01/03/2007 | EP1738769A1 Preparation for transferring nucleic acid into cell |
| 01/03/2007 | EP1738767A1 Bone morphogenic proteins (BMP), BMP receptors and BMP binding proteins and their use in the diagnosis and treatment of glaucoma |
| 01/03/2007 | EP1738643A1 Tlr ligand and il-1 response-injured animal model |
| 01/03/2007 | EP1737983A2 Method of inducing immunity against stratum corneum chymotrytic enzyme |
| 01/03/2007 | EP1737977A2 Methods and means for nucleic acid sequencing |